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Background: Macrophages in other organs (e.g. kidneys, lungs, and spleen, et. al) have rarely been reported in the
development of liver fibrosis. Therefore, it is important to investigate macrophage activation in the main organs in
liver fibrosis. We investigated the potential antifibrogenic effects of paeoniflorin (PF) in a dimethylnitrosamine
(DMN)-induced rat model with special focus on inhibiting macrophage activation in the main organs.
Methods: Rat hepatic fibrosis was induced by treatment with DMN three times weekly over a 4-week period. DMN
rats were treated with water, PF, or gadolinium chloride (GdCl3) from the beginning of the 3
rd week. The expression of
CD68, marker of macrophage, was investigated using immunohistochemical, real-time PCR, and western blot analysis.
Results: Hepatic hydroxyproline content markedly decreased and histopathology improved in the DMN-PF rats.
Expression of desmin and collagen 1 decreased notably in DMN-PF liver. CD68 expression in the liver, spleen and
kidney increased markedly after 2 weeks but decreased in DMN-water rats. PF and GdCl3 decreased CD68 expression in
the liver and spleen and there was no effect on kidney. CD68 expression in the lung increased gradually during the
course of DMN-induced liver fibrosis, and PF inhibited CD68 expression in the lung significantly while GdCl3 increased
CD68 markedly. Expression of tumor necrosis factor (TNF-α) was decreased significantly by GdCl3 in the liver, as
revealed by real-time PCR analysis. However, GdCl3 could not decrease TNF-α level in the serum by enzyme linked
immunosorbent assay (ELISA).
Conclusions: Macrophage activation was disrupted in the liver, spleen, lung and kidney during development of
DMN-induced liver fibrosis. PF administration attenuated DMN-induced liver fibrosis at least in part by regulating
macrophage disruption in the main organs.
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Hepatic fibrosis, which is characterized by progressive in-
flammation and deposition of extracellular matrix (ECM)
components, is a common response to chronic liver dis-
ease [1]. Hepatic stellate cell (HSC) activation represents a
critical event in fibrosis because these cells become the
primary source of ECM in liver upon injury [2,3]. The
macrophages can stimulate HSC activation by secreting
tumor necrosis factor (TNF)-α [2]. To elucidate the role* Correspondence: xiaorong3chen@yahoo.com.cn
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reproduction in any medium, provided the orof macrophages in the pathogenesis of liver fibrosis, spe-
cific macrophage blocking agents such as gadolinium (III)
chloride (GdCl3) have been used. When administered
intravenously, GdCl3 inhibits phagocytosis by rat liver
macrophages and selectively eliminates the large macro-
phages in the periportal zone of the acinus [3]. Accumu-
lating evidence has suggested that macrophages play a key
role in liver fibrosis [4-6], whereas macrophages in other
organs (e.g. kidneys, lungs, and spleen) have been rarely
reported and often neglected by those investigating deve-
lopment of liver fibrosis. In fact, other organs such as the
spleen, lungs, and kidneys are all involved in liver fibrosis
[7-9]. Thus, there is an urgent need to study the dynamic
changes of macrophage activation in the main organs in
liver fibrosis in vivo.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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cipal bioactive component of Radix Paeoniae Rubra of
Chinese traditional herbs. PF may be effective for treat-
ment of stroke, as demonstrated using a rat middle cere-
bral artery occlusion model [10]. PF has been shown to
attenuate the contraction induced by veratrine in isolated
atria and aorta of rats [11]. It can inhibit nuclear factor κB
activity of SGC-7901 cells, and enhance 5-fluorouracil-
induced apoptosis of gastric carcinoma cells in a time-
and dose-dependent manner [12,13]. PF might alleviate
hepatic fibrosis caused by Schistosoma Japonicum, and the
inhibitory effect might be associated with its ability to
interfere with the interleukin (IL)-13 signaling molecule
[14]. However, little is known about the effects of PF on
macrophages in the main organs during the development
of liver fibrosis.
To investigate the mechanism by which PF acts on liver
injury, we investigated the potential antifibrogenic effects
of PF in an experimental liver fibrosis rat model, with a
special focus on the mechanisms regulating macrophage
activation in the liver, spleen, kidneys and lungs. We were
interested in: (1) whether macrophages in other organs
such as the spleen, lungs and kidneys changed during
dimethylnitrosamine (DMN)-induced liver fibrosis; and
(2) the regulatory effects of PF on macrophages in other
organs in DMN-induced liver fibrosis.
Methods
Main reagents
GdCl3 and PF were obtained from Sigma-Aldrich (St Louis,
MO, USA), DMN was from Wako (Osaka, Japan). Sirius
Red was obtained from Polysciences (St Louis, MO, USA)
and dissolved in saturated picric acid (Chroma, Munster,
Germany). SuperSignal West Pico Chemiluminescent
Substrate was from Thermo Scientific (Rockford, IL,
USA), SYBR Green Supermix was from Fermentas (Glen
Burnie, MD, USA). Prestained protein marker was pur-
chased from New England Biolabs (Beijing, China). Mouse
desmin antibody was purchased from Abcam (Cambridge,
UK) and diluted at a 1:100 ratio (ab8470), and mouse
α-smooth muscle actin (SMA) mouse antibody was
from Sigma and diluted at 1:400. Mouse glyceralde-
hyde 3-phosphate dehydrogenase (GAPDH) antibody was
purchased from Kangchen (Shanghai, China) and diluted
1:5000, and mouse CD68 antibody was purchased from
Serotec (Boston, MA, USA) and prepared at 1:100 dilution.
Animals
Male Wistar rats were supplied by the Central Animal
Care Facility of Shanghai Public Health Clinical Center
(Permission No: SCXK 2007–0006). The rats received
humane care with unlimited accesses to chow food and
water during the study. All of the study protocols com-
plied with the current ethical considerations of ShanghaiPublic Health Clinical Center’s Animal Ethic Committee
and the procedural and ethical guidelines of the Chinese
Animal Protection Act, which is in accordance with the
National Research Council criteria. All animal experi-
ments and procedures were reviewed and approved by the
Institutional Animal Care and Use Committee (IACUC)
of Shanghai Public Health Clinical Center and were per-
formed in accordance with the relevant guidelines and
regulations.
Experimental design
Liver fibrosis was induced in adult rats over a 4-week
period by three times weekly intraperitoneal injection of
10 mg/kg DMN dissolved in sterile saline [15]. At the
end of the 2nd week, three rats each from the control and
DMN-treated groups were sacrificed to assess fibrosis de-
velopment. At the beginning of week 3, DMN-treated rats
were randomly assigned into the DMN-PF (n=7), DMN-
GdCl3 (n=7), and DMN-water groups (n=7) for 2 weeks.
Every group continued to receive weekly DMN treatment
for a further 2 weeks, in addition to administration of PF,
GdCl3, or water. The PF (20 mg/kg/day) was dissolved in
water and administered by gavages. The GdCl3 in sterile sa-
line was administered intravenously (i.v.) twice weekly with-
out anesthesia through the tail vein at a dose of 7 mg/kg
body weight [16]. At the end of the week 4, all of the ani-
mals were sacrificed. For sampling, excised livers were
transferred to PBS solution, in which they were cut into
pieces. These were either immediately shock frozen in li-
quid nitrogen and subsequently kept for further analyses
or directly transferred into buffered 10% formaldehyde so-
lution for paraffin embedding.
Hydroxyproline assay
Snap-frozen liver samples (80–100 mg) were weighed,
hydrolyze in 2.5 ml of 6M HCl at 110°C for 18 h [17] and
h hydroxyproline content was expressed as μg/g liver.
Liver function tests
Serum alanine aminotransferase (ALT), aspartate amino-
transferase (AST), albumin (Alb) and total bilirubin
(TBil) were evaluated in samples obtained at the end of
the experiment. Activity was evaluated by using a com-
mercial clinical test kit (Jiancheng Institute of Biotech-
nology, Nanjing, China) according to manufacturer’s
instructions.
Histopathology
The main organs such as liver, lungs spleen, kidneys,
heart and brain were fixed in 4% paraformaldehyde, em-
bedded in paraffin, and sectioned. Sections were stained
with hematoxylin and eosin (H&E), Sirius red and
immunostaining. Liver specimens were preserved in 10%
formaldehyde, dehydrated in a graded alcohol series,
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ness, placed on glass slides, and stained with Sirius red.
Fibrosis was graded according to the method of Scheuer
as follows: grade 0, normal liver; grade 1, increased col-
lagen without formation of septa (small satellite expan-
sion of portal fields); grade 2, formation of incomplete
non-interconnecting septa, from portal tract to central
vein; grade 3, complete but thin interconnecting septa,
which divide the parenchyma into separate fragments;
and grade 4, complete cirrhosis, similar to grade 3 but
with thicker septa [18]. Three pathologists who were
blind to the treatment of the rat performed pathological
examinations. Fibrosis scores were given after thorough
examination of three different areas of the tissue slides
from each rat.
Western blotting
Western blotting was performed according to standard
methods, as previously described [19]. Tissue samples
were homogenized in ice-cold RIPA buffer. Samples were
then centrifuged for 10 min at 12,000 rpm. The super-
natant was collected, and the protein concentration was
measured using a commercial kit (Jiancheng Institute of
Biotechnology, Nanjing, China). Protein lysates (50 μg)
were separated by SDS-PAGE and subsequently trans-
ferred to nitrocellulose membranes. Membranes were
blocked with 5% nonfat dry milk incubation buffer
(BD, Sparks MD, USA) and incubated with antibodies
against rat CD68 and α-SMA. Secondary antibody was
used for chemiluminescent detection. Loading accuracy
was evaluated by monoclonal antibodies against GAPDH.
CD68 staining
After deparaffinization and dehydration, microwave anti-
gen retrieval was performed for 5 min prior to peroxidase
quenching with 3% H2O2 in PBS for 15 min. Subsequently,
sections were preblocked with 5% bovine serum albumin
for 30 min and incubated with a primary antibody (anti-
CD68) overnight at 4°C. A negative control was treated as
for the other samples except that primary antibodies were
replaced with PBS and no staining took place. After wash-
ing in PBS, sections were incubated with biotinylated
secondary antibody for 30 min and then stained with
3,3’-diaminobenzidine (Vector Laboratories, Burlingame,
CA, USA) for 2–5 min. Slides were finally counterstained
with hematoxylin for 2–3 min, mounted, and examined.
RNA preparation, reverse transcription, and real-time
quantitative PCR
Total RNA was isolated from liver tissue using Trizol
Reagent (Invitrogen, Carlsbad, CA, USA) according to the
manufacturer’s instructions. Two micrograms of RNA was
reverse-transcribed to cDNA using M-MLV Transcriptase
(Invitrogen, Carlsbad, CA, USA) in the presence of oligo-dT primers. Quantitative PCR was performed using SYBR
Green I (Glen Burnie, MD, USA) for 40 cycles at 15 sec-
onds at 95°C and 60 seconds at 60°C with Rotor-Gene
6000 (Corbett Research, Sydney, NSM, Australia) accord-
ing to the manufacturer’s instructions. qPCR primers were
are shown in Additional file 1: Table S1. Results were ana-
lyzed by double ΔCt method. Values were expressed as
fold change in comparison with control.
ELISA
The production of IL-1β (R&D Systems, Minneapolis,
MN, USA) and TNF-α (Biosource, Carlsbad, CA, USA) in
the serum were quantified using ELISA. ELISA was per-
formed using the Quantikine Kit according to the manu-
facturer’s protocols.
Statistical analysis
All the results are expressed as mean ± standard deviation
(SD). For group comparisons, if the samples satisfied normal-
ity assumption, a one-way analysis of variance Bonferroni’s
multiple comparison test was applied; If the samples failed
normality assumption, the non-parametric Kruskal-Wallis
statistic Dunn’s multiple comparison test. The analyses were
performed with GraphPad Prism 5.0 (GraphPad Software,
Inc., La Jolla, CA). Rank data (Additional file 1: Table S3)
were analyzed with ridit. Other data used in the manu-
script are all belong to measurement data such as
Tables 1, 2, 3, and 4, Figure 1C/1D, Figure 2A, and
Additional file 1: Table S2, et al. A P value < 0.05 was
considered statistically significant.
Results
PF improved survival rates in DMN-indcued liver fibrosis
in rats
During drug intervention, 2 rats died in the DMN-water
group, and 1 in the DMN-GdCl3 group. Animal body,
liver, lung, spleen, kidney, heart and brain weights were
monitored during the formation of liver fibrosis (Table 1).
Liver, spleen and lung weights increased significantly in
the 2-week DMN rats compared with those in the 2-week
normal group (p<0.05). Compared with 4-week normal
rats, body, liver, heart and kidney weights decreased sig-
nificantly in the 4-week DMN-water group (p<0.05),
whereas the spleen weight in the 4-week DMN-water rats
increased significantly (p<0.05). These results indicated
that other organs such as spleen, lungs, kidneys and heart
were damaged severely during cirrhosis. Compared with
4-week DMN-water rats, body, spleen and heart weights
decreased notably in the DMN-GdCl3 rats (p<0.05), and
spleen weight decreased significantly in the DMN-PF
rats (p<0.05).
Liver/body weight ratio of the DMN-water group was
significantly lower than that of the normal group (p<0.05).
Spleen/body, lung/body, kidney/body, heart/body and
Table 1 Effects of PF on body weight and main organs weight in DMN-induced rat liver fibrosis (x±s)














2-week normal(3) 199.33±9.45 6.81±0.61 0.54±0.11 0.56±0.09 0.75±0.12 1.16±0.10 1.04±0.02
2-week DMN(3) 180.33±0.55 7.67±0.47 0.77±0.06⋆ 0.50±0.01▴ 0.93±0.06⋆ 1.37±0.06 1.10±0.00
4-week normal(7) 273.90±12.29▴ 10.03±0.86▴ 0.59±0.09⋆ 0.81±0.07▴ 1.00±0.00 1.64±0.15▴ 1.17±0.05
DMN-water(5) 201.50±17.81 5.92±1.64 1.38±0.30☆ 0.72±0.07△ 1.05±0.11☆ 1.43±0.08 1.20±0.10
DMN-PF(7) 208.87±18.46 6.45±1.21 1.13±0.22 0.66±0.05 1.00±0.00 1.46±0.13 1.17±0.05
DMN-GdCl3(6) 183.48±13.99▴ 4.73±0.41 1.11±0.08 0.63±0.08▴ 1.07±0.10 1.65±0.26▴ 1.13±0.12
△p<0.05 versus the same period in 2-week DMN rats; ▴p<0.05 versus the same period in DMN-water rats.
Bonferroni’s multiple comparison test were used for group comparisons in body weight, liver weight, heart weight, and kidneys weight.
☆p<0.05 versus the same period in 2-week DMN rats; ⋆p<0.05 versus the same period in DMN-water rats. Kruskal-Wallis test were used for group comparisons in
liver weight, spleen weight, lung weights, and brain weight.
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the 4-week DMN-water rats compared with those in the
4-week normal rats (Additional file 1: Table S2). The liver/
body weight ratio of the PF rats was higher than that of
the DMN-water group but there were no significant dif-
ference (p<0.05).
PF ameliorated liver function in DMN-induced liver
fibrosis
Liver function parameters deteriorated over time in rats
subjected to DMN (Table 2). DMN-treated rats developed
hepatic injury as shown by significantly higher plasma
concentrations of AST, ALT, ALP and TBil, and a lower
concentration of TP and Alb compared with normal rats.
PF treatment ameliorated significantly the increase of
ALT, AST, ALP and TBil, and the decrease of Alb com-
pared with 4-week DMN-water rats (p<0.05), while GdCl3
decreased ALP levels significantly (p<0.05).
PF improved histology in DMN rats
Pathological changes occurred in the liver during devel-
opment of fibrosis, which was confirmed by H&E stain-
ing, and in the spleen, lungs and kidneys (Figure 1). In
the liver, there was normal lobular architecture, with the
central vein and radiating hepatic cords in the livers of
normal rats (Figure 1). After DMN intoxication for 2
weeks, we observed massive hepatocyte necrosis, intenseTable 2 Effects of PF on serum parameters in DMN-induced r
Group(number) ALT(U/L) AST(U/L) ALP
Normal (10) 25.14±2.86△▴ 79.00±5.83△▴ 226.71±
2-week DMN (3) 90.33±3.21▴ 182.67±11.93▴ 395.00
DMN-water (5) 256.80±144.26△ 549.40±260.71△ 667.60
DMN-PF (7) 127.43±20.19▴ 234.86±42.56▴ 394.00
DMN-GdCl3(6) 230.20±43.27 425.60±79.67 610.80
Δp<0.05 versus 2-week DMN rats; ▴p<0.05 versus DMN-water rats. Bonferron’s multi
and Alb.
☆p<0.05 versus 2-week DMN rats; ⋆p<0.05 versus DMN-water rats. Kruskal-Willam teneutrophil infiltration, and initiation of fibrosis (Figure 1).
In the DMN-water group, the liver sections revealed colla-
gen fiber deposition, marked cirrhosis, and severe centri-
lobular necrosis. We observed marked reduction in the
thickening of the collagen bundles in the DMN-PF group.
In normal spleen, the white pulp was circular or oval
and consisted mainly of lymphocytes and the red pulp
contained mainly red blood cells, and macrophages sur-
rounded the white pulp (Figure 1). The spleen showed
clear structural damage in the 2-week DMN rats; the
white pulp was irregular in shape and the circular region
had almost disappeared. The white pulp structure was
restored in the 4-week DMN rats. GdCl3 had a positive
protective effect on spleen structural restoration.
In normal lungs, there was no inflammatory cell infiltra-
tion and alveolar structure was normal. Alveolar structural
damaged gradually developed after DMN treatment
(Figure 1). There was a large amount of inflammatory cell
infiltration in the alveolar walls and spaces. PF could re-
duce alveolar inflammatory cell invasion significantly in
the lungs.
Normal kidney was characterized by clear organizational
structure, and there was almost no macrophage infiltra-
tion (Figure 1). A lot of renal tubular epithelial cell swel-
ling, necrosis and inflammatory cell infiltration appeared
in 2-week DMN rats. Macrophage infiltration clearly
decreased in kidneys of 4-week DMN rats. However, thereat liver fibrosis (x±s)
(U/L) TP (g/L) Alb (g/L) TBil(μmol/L)
24.68△▴ 57.60±1.95△▴ 29.15±1.13△▴▴ 2.40±0.08⋆
±53.11▴ 48.53±4.55▴ 26.33±1.82▴▴ 3.30±0.17⋆
±41.20▴ 30.82±5.02△ 18.94±0.89△△ 79.00±21.13☆
±34.03▴ 46.98±3.73▴ 25.37±1.96▴▴ 31.97±12.34⋆
±51.16▴ 34.14±3.06 20.68±3.05 68.96±15.07
ple comparison test were used for group comparisons in ALT, AST, ALP, TP,
st were used for group comparisons in TBil.
Table 3 Effect of PF on TNF-α and IL-1β levels in the
serum in DMN-induced rat liver fibrosis (x±s)
Group (number) TNF-α (pg/L) IL-1β (pg/L)
Normal (5) 35.44±5.64△▴ 26.70±3.56△▴
2-week DMN (3) 896.51±78.06▴ 954.71±75.28▴
DMN-water (5) 758.72±61.54△ 647.66±95.54△
DMN-PF (5) 446.95±42.90▴ 471.34±26.67▴
DMN-GdCl3 (5) 708.03±78.84 705.63±99.46
△p<0.05 versus 2-week DMN rats; ▴p<0.05 versus DMN-water rats. Bonferroni’s
multiple comparison test was used for group comparisons in TNF-α and IL-1β.
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with other organs in DMN-induced liver fibrosis (data not
shown).
PF inhibited liver fibrosis in DMN rats
We evaluated whether PF inhibited hepatic fibrosis. Sirius
Red staining clearly revealed accumulation of ECM, espe-
cially collagen. As shown in Figure 2A, collagen staining
was scarcely observed in the normal liver samples, except
in the area around the small central venous walls. In
DMN-treated liver samples at 2 weeks, collagen stretched
from the portal to lobular areas (Figure 2A). Additional cir-
rhotic nodule formation was seen in 4-week DMN-treated
rats. Liver fibrosis was attenuated extensively by PF, which
had better effects than GdCl3. Ridit analysis showed that
there was a significant difference between the DMN-PF
and DMN-water rats (p<0.05), but the DMN-GdCl3 inter-
vention group did not differ significantly (Additional file 1:
Table S3).
Using antibody against desmin, a marker of stellate cell
activation, we assayed the expression of this protein
immunohistochemically (Figure 2B). In the normal rats,
only vascular smooth muscle cells were strongly positive
for desmin. After 2 weeks DMN treatment, desmin-
positive HSCs were detected in areas of centrilobular and
near periportal fibrotic bands. The number of desmin-
positive HSCs was even higher in 4-week DMN-treated
cirrhotic livers. After treatment with PF, the increased ex-
pression of desmin was markedly decreased. These results
revealed the antifibrogenic effects of PF. Hepatic hydroxy-
proline content gradually increased in DMN-treated ratsTable 4 Effects of PF on transcript levels of proinflammatory




IL-1β (n-fold) TNF-α (n-fold) IL-1β (n-fold) TNF-α (
Normal (3) 1.20±0.18△△▴▴ 1.30±0.29△▴ 1.38±0.40△▴ 1.41±0
2-week DMN (3) 4.98±0.67 11.64±2.24▴ 4.74±1.49 3.71±
DMN-water (3) 3.89±0.72 6.09±1.86△ 3.80±1.36 3.38±
DMN-PF (3) 2.97±0.39 4.50±0.74 2.82±0.30 2.28±
DMN-GdCl3 (3) 3.52±0.84 3.49±0.75▴ 3.37±1.16 2.68±
Δp<0.05 versus 2-week DMN rats; ▴ p<0.05 versus DMN-water rats. Bonferroni’s mulgradually (Figure 2C). PF treatment ameliorated signifi-
cantly the increase of hydroxyproline content, compared
with 4-week DMN-water rats (p<0.05).
Sustained deposition of ECM is mainly resulted from ac-
tivation of HSCs; therefore, a correlation between accumu-
lated collagen and activated HSCs was studied by detecting
a marker of activated HSCs, α-SMA in liver sections
described above. We detected the α-SMA and Collagen 1
α1 (Col1α1) by real-time PCR (Figure 2D). There was a
gradual increase in their expressions and PF significantly
attenuated the upregulation of α-SMA and Col1 (α1) sig-
nificantly. Changes in expression of desmin and Col1 (α1)
were also demonstrated by western blotting (Figure 2E).
Taken together, these results confirm that DMN
administrations cause HSC activation and accumulation
of ECM that might facilitate liver fibrosis and PF could
inhibit DMN-induced liver fibrosis.
Macrophage activation disturbed in main organs in DMN-
induced liver fibrosis
Liver macrophages/Kupffer cells were important contribu-
tors to fibrosis progression. However, macrophages in
other organs have rarely been detected in previous studies.
To elucidate the function of macrophages in liver fibrosis,
a specific macrophage marker, CD68, has been used to
monitor macrophage activation [4]. As shown in Figure 3,
CD68-positive macrophages were present in hepatic sinu-
soids and were at very low levels in normal liver. After
DMN treatment, CD68-positive macrophages with strong
staining appeared not only in hepatic sinusoids, but also
in portal areas and adjacent to fibrotic septa. PF and
GdCl3 decreased CD68 expression compared with that in
DMN-water rats.
The CD68-positive macrophages were at a relative high
level and mainly located in the red pulp in normal spleen
(Figure 3). CD68-positive macrophages increased signifi-
cantly around the disrupted white pulp in 2-week DMN
rats and decreased markedly in DMN-water rats. PF and
GdCl3 inhibited CD68-positive macrophages markedly.
CD68-positive pulmonary macrophages with low ex-
pression in the lung in normal rat distributed widely in
the alveolar, bronchial, pulmonary interstitial. Macrophagecytokines TNF-α and IL-1β in different organs in
Lung Kidney
n-fold) IL-1β (n-fold) TNF-α (n-fold) IL-1β (n-fold) TNF-α (n-fold)
.50△▴ 1.14±0.27△▴ 1.44±0.47△▴ 1.36±0.37△ 1.33±0.28△
0.44 9.00±1.39 7.41±1.37▴ 4.46±0.68▴ 6.72±1.68▴
0.47 11.09±3.34 11.24±2.13△ 1.99±0.53△ 2.24±0.57△
0.34▴ 4.09±0.97▴ 3.13±0.28▴ 1.76±0.19 1.70±0.19
0.46 9.73±1.85 10.07±2.53 1.69±0.30 1.55±0.45
tiple comparison test were used for group comparisons.
Figure 1 Effects of PF on H&E staining in different organs in DMN-induced rat liver fibrosis ×200 magnification.
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and reached a peak in 4-week DMN-water rats. PF
decreased the number of CD68-positive macrophages sig-
nificantly; however, GdCl3 had no such effect.
Immunostaining with CD68 antibody showed marked ac-
cumulation of CD68-positive macrophages in the kidneys
after 2 weeks DMN treatment. However, CD68-positive
macrophages in the kidneys were decreased markedly in
DMN-water rats. Administration of PF and GdCl3 had no
obvious effects on macrophages in kidneys compared with
that in DMN-water rats.
Real-time PCR showed that CD68 transcripts were
upregulated about 6.7-fold after 2 weeks DMN treatment
(Figure 4A). Thereafter, mRNA expression declined
slightly in the 4-week DMN-treated liver. Similar changes
at the protein level of CD68 were observed by western
blotting (Figure 4B). Expression of CD68 in the spleen and
kidneys was similar. CD68 expression in the spleen and
kidneys in DMN-water rats decreased to a level below that
in normal rats. PF and GdCl3 did not inhibit CD68 expres-
sion significantly in the spleen and kidneys. Unlike CD68
expression in the liver, kidneys and spleen, it increased
gradually following DMN administration in the lungs. PF
reduced CD68 expression, whereas GdCl3 even increased
CD68 expression. These results were also confirmed by
western blotting.PF but not GdCl3 inhibited serum levels of TNF-α and IL-1β
One of important function of macrophages is to se-
crete proinflammatory factors, so we decided to detect
proinflammatory cytokines in the serum. The level of
TNF-α and IL-1β was low in normal serum and increased
to 25.3- and 35.7-fold following 2 weeks DMN-treatment,
respectively (Table 3), compared with that of the normal
rats, and decreased markedly in DMN-water rats. PF but
not GdCl3 decreased TNF-α and IL-1β significantly. The
cytokines content in the serum represents the overall level
in the body, and these proinflammatory cytokines are
mainly derived from macrophages.Inflammatory cytokines could derive from other organs
besides the liver
We detected TNF-α and IL-1β in the liver, spleen, lungs
and kidneys using real-time PCR. IL-1β transcripts were
up-regulated 4.15-fold, 3.43-fold, 7.89-fold and 3.28-fold in
the liver, spleen, lungs, and kidneys, respectively, in 2-week
DMN rats (Table 4). Afterwards, IL-1β decreased in the
liver, spleen and kidneys in DMN-water rats while it
increased in the lungs in DMN-water rats (p>0.05) com-
pared with that in the 2-week DMN rats. PF could inhibit
the IL-1β transcription significantly in the lungs compared
with DMN-water rats (Table 4).
Figure 2 Effects of PF on histological changes. A, Sirius Red staining, ×100 magnification; B, desmin staining, brown staining indicates
immunopositivity ×200 magnification, n=3; C, Hyp content; The number in Hyp and sirius red detection was the same as the number of animals
in each group, data as mean ±SD, ☆p<0.05 versus 2-week DMN rats; ⋆p<0.05 versus DMN-water rats. Kruskal-Wallis test was used for group
comparisons in Hyp. D, α-SMA and Col1(α1) using real-time PCR analysis, as an internal control, 18S rRNA was amplified (n=3), data as mean ±SD,
▴p<0.05 versus DMN-water rats; Δp<0.05 versus 2-week DMN rats. Bonferroni’s multiple comparison test were used for group comparisons in
α-SMA and Col1(α1). E, the expression of desmin and Col1(α1) was analyzed using western blot in rat livers with DMN-induced liver fibrosis
(n=3); western blotting of total protein extracts with antibodies recognizing desmin, Col1(α1), and GAPDH respectively.
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markedly compared with that of DMN-water rats. How-
ever, GdCl3 almost did not decrease TNF-α transcripts in
the lungs. PF significantly suppressed the TNF-α expres-
sion in the spleen and lungs significantly (p <0.01 or 0.05)
compared with that of DMN-water rats (Table 4).
Discussion
The present study demonstrates that macrophage activation
is disrupted in the liver, spleen, lungs and kidneys during
liver fibrosis development. The macrophages in the lungs
might also play a key role in DMN-induced liver fibrosis.
PF administration attenuates liver fibrosis at least in part by
regulating the macrophages in the main organs.
Liver fibrosis is considered as an outcome of chronic
liver injury during long-term wound healing, which
causes increasing amounts of ECM deposition in the
liver and eventually leads to liver fibrosis and later cir-
rhosis [20-22]. Despite advances in the understanding of
liver fibrosis, the landmark isolation of HSCs and dem-
onstration of their in vitro activation resulted in 30 years
of fibrosis research focused on understanding HSC be-
havior in culture and applying these findings to animal
models of disease [23]. However, translation of thisknowledge into antifibrotic therapies has a long way to go.
All these results have indicated that microenvironment
and the “whole conception” are more important than just
focusing only on one cell type.
Inflammation to repeated injury and repair is at the root
of hepatic fibrosis [24]. The inflammatory process that
results from injury is characterized by the production of
soluble mediators, including cytokines such as TNF-α and
IL-1β derived from macrophages. Prior clinical and ex-
perimental evidence indicates that the inflammatory re-
sponse in cirrhosis is not restricted to the liver, but
extends to the systemic circulation and other organs such
as the spleen, lungs, kidneys, et al. [25,26]. Given the
pathogenic role of inflammation in tissue damage in cir-
rhosis, modulation of the inflammatory response is a
therapeutic target. Researchers have reported that simul-
taneous administration of GdCl3 prevents pig serum and
DMN-induced rat liver fibrosis with reduced the expres-
sion of α-SMA and procollagen I [27]. Ide reported that
pretreatment with GdCl3 had less prominent therapeutic
effects in thioacetamide-induced liver fibrosis [28].
There was a problem in all these studies, in that research-
ers detected the macrophage function in liver fibrosis
using specific blocker GdCl3, while macrophages in other
Figure 3 Effects of PF on CD68 using immunohistological staining in different organs in DMN-induced rat liver fibrosis. CD68 was
investigated by brown staining indicates immunopositivity ×400 magnification, n=3.
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about the proinflammatory cytokines in other organs in
liver fibrosis? These soluble proinflammatory cytokines
within the blood reached the liver, thereby affecting the
process of liver fibrosis. Therefore, urgent investigation is
needed of these cytokines in other organs in liver fibrosis.
Liver injury could be associated with macrophage ac-
tivation and trigger migration of macrophages into hep-
atic cords in which they stimulate fibrosis by secreting
proinflammatory cytokines. In fact, liver fibrosis is a
systemic disease that involves many organs such as the
spleen, kidneys, and lungs. The current results showed
that macrophages and proinflammatory cytokines were dis-
rupted in the liver, lungs, spleen, and kidneys during the de-
velopment of liver fibrosis. Other researchers have shown
that macrophage activation in the brain in hepatitis-C-
virus-infected patients [29]. However, we did not detect
CD68 expression in the brain and heart during DMN ad-
ministration, which may have been due to expression of
CD68 being too low to detect using western blotting.
We showed that macrophages in different organs varied
widely and GdCl3 had different effects on them. The
trends in expression of CD68 and proinflammatory cyto-
kines in the spleen and kidneys were similar in some ex-
tent; they reached a peak in 2-week DMN rats, and then
decreased significantly in 4-week DMN rats. These resultsindicated that proinflammatory cytokines might derive
mainly from macrophages; and that macrophages in kid-
neys and spleen could play a lesser role, because they
decreased to near or below the normal levels in 4-week
DMN rats. However, the expression of CD68 and proin-
flammatory cytokines increased gradually in the lung fol-
lowing DMN-treatment, but to our surprise, GdCl3 did
increase CD68 expression in the lungs compared with that
in DMN-water rats. Based on our knowledge, GdCl3 defin-
itely had an inhibitory effect on liver macrophages (Kupffer
cells). However, the effects of GdCl3 on macrophages in the
lungs are more controversial. Some researchers have
reported that GdCl3 has no effect on lung macrophages (at
the dose of 10 or 20 mg/kg, i.v.) [30,31], but others have
demonstrated in increase in the number of macrophages
and expression of inflammatory mediators after GdCl3
treatment (10 mg/kg, i.v.) [32]. There were two reasons for
this phenomenon. First, signals from proinflammatory cyto-
kines could enhance the expression of adhesion molecules
and chemotactic factors, leading to increases in the number
of infiltrating macrophages into the lungs [33]. TNF-α
mRNA expression was increased after GdCl3 treatment in
the lungs of rats with DMN-induced liver fibrosis. The
TNF-α signal induced macrophage infiltration. Second,
Kupffer cells have been suggested to be heterogeneous
macrophage lineage cells and have two subpopulations
Figure 4 Effects of PF on CD68 expression in different organs in DMN-induced rat liver fibrosis. (A) CD68 was measured by real-time PCR.
As an internal control, 18S rRNA was amplified. The data represented the mean ± SD. ▴p<0.05 and ▴▴p<0.01 versus DMN-water rats; △p<0.05 and
△△p<0.01 versus 2-week DMN rats; LSD test were used for group comparisons in CD68 detection in the liver and lung.☆p<0.05 versus 2-week
DMN rats; ⋆p<0.05 versus DMN-water rats Kruskal-Wallis test were used for group comparisons in CD68 detection in the spleen and kidney, n=3.
(B) CD68 were detecting by western blotting.
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CD163), based on their phenotype and function [34].
GdCl3 can inhibit/inactivate ED2 macrophages but does
not inhibit ED1 macrophages, and it has been reported
that ED2 macrophages can transform into ED1 macro-
phages [34]. GdCl3 might inhibit ED2 macrophages, which
are transformed into ED1 macrophages in the lungs inDMN-induced liver fibrosis, so the number of ED1
macrophages (CD68 expression) increased in the lungs.
Although GdCl3 decreased IL-β and TNF-α in the
liver, spleen and kidneys, it did not reduce proinflamma-
tory cytokines significantly in the serum and lung tissue.
These may be related to the GdCl3-induced increase in
CD68 and proinflammatory cytokines, which leads to no
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improvement in liver fibrosis. PF could decrease CD68 ex-
pression significantly in the lungs and liver. PF decreases
proinflammatory cytokine expression markedly in the
lungs and serum. By comparison, the anti-fibrotic effects
of GdCl3 and PF in DMN-induced liver fibrosis, we could
conclude that macrophages in other organ, at least in part,
play an important role in liver fibrosis.
Conclusions
The present study demonstrated that PF is able to im-
prove the histological changes and reduce ECM accumu-
lation during DMN-induced liver fibrosis. The relevant
mechanism involves inhibiting macrophage disruption in
the liver and lungs. These results indicate that one single-
targeted blocker is limiting and giving rise to a new con-
cept, in which liver fibrosis is not restricted to the liver,
but also involves many other organs. Macrophage activa-
tion is disrupted in the liver, spleen, lungs and kidneys in
DMN-induced liver fibrosis development. PF administra-
tion attenuates DMN-induced liver fibrosis at least in part
by regulating the disrupted macrophages in the main
organs.
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